Publications

Yildiz M, Brugger F, Kästle N, Tettenborn B. Neurocognitive impairment and corpus callosum atrophy in multiple sclerosis. Neurology, Psychiatry and Brain research. Volume 22, Issues 3-4, December 2016, Pages 173-177

Yildiz M, Tettenborn B, Radue EW, Bendfeldt K, Borgwardt S. Association of cognitive impairment and lesion volumes in multiple sclerosis - A MRI study. Clin Neurol Neurosurg. 2014 Dec;127:54-8. doi: 10.1016/j.clineuro.2014.09.019. Epub 2014 Oct 14.

Ulmer A, Dietz K, Hodak D, Polzer B, Scheitler S, Yildiz M, Schanz S, Röcken M, Garbe C, Breuninger H, Fierlbeck G, Klein CA: Quantitative measurement of melanoma spread in sentinel lymph nodes and survival. PLOS Medicine. IN PRESS

Yildiz M, Tettenborn B, Borgwardt S. Trajectory of fatigue in natalizumab treated multiple sclerosis patients. Clinical Neurology and Neurosurgery.115 902– 903.

Yildiz M. Slower Walking Speed Limits the Activities of Daily Living of Multiple Sclerosis Patients. International Journal of Clinical Practice. 2012 Nov; 66(11):1188-94.

Yildiz M, Borgwardt S, Berger G. Parietal lobes in schizophrenia: Do they matter? Schizophrenia Research and Treatment. Volume 2011, Article ID 581686, doi:10.1155/2011/581686

Haltmeier S, Yildiz M, Müller S, Anliker MD, Heinzerling L. Contact dermatitis induced by glatiramer acetate. Mult Scler. 2011 Nov;17(11):1390-2. Epub 2011 Jul 52011 Yildiz M, Tettenborn B. Fatigue und Multiple Sklerose. Info Neurologie&Psychiatrie 4/2011.

Yildiz M, Tettenborn B, Putzki N: 25-hydroxyvitamin D Levels in Swiss Multiple Sclerosis Patients. Swiss Med Wkly. 2011; 141: w13192.

Yildiz M, Tettenborn B, Putzki N: Multiple Sclerosis associated Fatigue during Disease Modifying Treatment with Natalizumab, Interferon-beta and Glatirameracetate. Eur Neurol 2011; 65: 231–232.2010

Yildiz M, Tettenborn B, Putzki N. Natalizumab and Beyond. Eur Neurol. 2010 Sep 4; 64(4): 236-240

Yildiz M, Pflüger M, Riecher-Rössler A and Berger G: Aneurysms of pericallosal cerebral artery haemorrhage with consecutive psychosis. Australian and New Zealand Journal of Psychiatry 2007; 41(6): 554

Berger G, Yildiz M, Aston J, Gschwandtner U, Riecher-Rössler A: Früherkennung psychotischer Störungen – ein praktischer Leitfaden. The Medical Journal 2007; 2: 29-32

Yildiz M, Borgwardt S, Fusar-Poli P: Is a DNA sequence variation of the gene protocadherin Y a possible explanation for the six-fold higher risk to develop schizophrenia in Moroccan males? Medical Hypotheses 2007; 69(3):694

Yildiz M, Borgwardt S: Apoptosis may be the main cause for acceleration of normal changes in adolescent brain structure, leading to the onset of psychosis. Medical Hypotheses. 2008. 70(3): 706-7

Yildiz M. Slower Walking Speed Limits the Activities of Daily Living of Multiple Sclerosis Patients. Submitted for European Neurological Society 21st Meeting 2011 in Lisbon, Portugal